There is increasing information on the effectiveness of different intervent
ions intended to reduce the gap between clinical practice and what is indic
ated by evidence on the effectiveness and cost-effectiveness of clinical in
terventions. Interventions include behavioural and financial/organizational
. Unfortunately, none of the interventions have a substantial impact upon c
linical practice. Many interventions that are evaluated are poorly develope
d, and there are several common methodological weaknesses in many of the ev
aluations conducted. The paper concludes with a comment on the nature of th
e market place for health technologies, and suggests that 'implementation i
nterventions' may not be the solution to the problems of the poor uptake of
medical research.